Inside of a the latest research, we claimed the identification and also the characterization of a new atypical opioid receptor with exclusive adverse regulatory properties to opioid peptides.1 Our success showed that ACKR3/CXCR7, hitherto known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, can be a broad-spectrum https://angelinae273xog9.blogsuperapp.com/profile